Biogen Inc.
DE ˙ DB ˙ US09062X1037
162,20 € ↑3,64 (2,30%)
2026-06-03
DEL PRIS
SecurityDE:IDP / Biogen Inc.
InstitutionMather Group, Llc.
Latest Disclosed Ownership1,534 shares
Latest Disclosed Value $ 281,230
Mather Group, Llc. reports 19.66% increase in ownership of IDP / Biogen Inc.

On April 13, 2026 - Mather Group, Llc. filed a 13F-HR form disclosing ownership of 1,534 shares of Biogen Inc. (DE:IDP) valued at $238,154 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 13, 2026 disclosing 1,282 shares of Biogen Inc.. This represents a change in shares of 19.66% during the quarter. The current value of the position is $248,815 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F BIOGEN COM 09062X103 1,534 252 19.66 281 24.89 0.0028
2026-01-13 2025-12-31 13F BIOGEN COM 09062X103 1,282 380 42.13 226 78.57 0.0023
2025-10-21 2025-09-30 13F BIOGEN COM 09062X103 902 902 126 0.0013
2025-07-15 2025-06-30 13F BIOGEN COM 09062X103 0 -2,767 -100.00 0 -100.00
2025-04-25 2025-03-31 13F BIOGEN COM 09062X103 2,767 1,039 60.13 379 43.18 0.0044
2025-01-27 2024-12-31 13F BIOGEN COM 09062X103 1,728 1,428 476.00 264 355.17 0.0034
2024-10-07 2024-09-30 13F BIOGEN COM 09062X103 300 -923 -75.47 58 -77.95 0.0007
2024-07-09 2024-06-30 13F BIOGEN COM 09062X103 1,223 181 17.37 264 -2.23 0.0032
2024-04-09 2024-03-31 13F BIOGEN COM 09062X103 1,042 -6 -0.57 270 -0.74 0.0043
2024-02-05 2023-12-31 13F BIOGEN COM 09062X103 1,048 -115 -9.89 271 -9.36 0.0043
2023-11-13 2023-09-30 13F BIOGEN COM 09062X103 1,163 -474 -28.96 299 -35.84 0.0053
2023-08-08 2023-06-30 13F BIOGEN COM 09062X103 1,637 1,637 466 0.0074
2022-02-15 2021-12-31 13F BIOGEN COM 09062X103 0 -721 -100.00 0 -100.00
2021-11-04 2021-09-30 13F BIOGEN COM 09062X103 721 68 10.41 204 -9.73 0.0049
2021-08-13 2021-06-30 13F BIOGEN COM 09062X103 653 -82 -11.16 226 9.71 0.0057
2021-05-14 2021-03-31 13F BIOGEN COM 09062X103 735 735 206 0.0058
2021-02-12 2020-12-31 13F BIOGEN COM 09062X103 0 -963 -100.00 0 -100.00
2020-11-13 2020-09-30 13F BIOGEN COM 09062X103 963 -433 -31.02 273 -26.81 0.0107
2020-08-14 2020-06-30 13F BIOGEN COM 09062X103 1,396 1,396 373 0.0171
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.